Gene · 8685
Papers1,530
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,530
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Macrophage ferroptosis potentiates GCN2 deficiency induced pulmonary venous arterialization. | Nat Commun | 2025 | 40983649 | PubTator, text mining | PubMed |
| Differential expression and regulation of FASLG by miR-5195/miR-3941 in age-related hearing loss. | PLoS One | 2025 | 40971385 | PubTator, text mining | PubMed |
| Dual RNA isolation from blood: an optimized protocol for host and bacterial RNA purification for dual RNA-sequencing analysis in whole blood sepsis samples. | Microb Genom | 2025 | 40965975 | PubTator, text mining | PubMed |
| High-plex imaging of hepatoblastoma and adjacent liver in pediatric patients reveals a predominant myeloid infiltrate expressing immune-checkpoints. | Cancer Immunol Immunother | 2025 | 40944713 | PubTator, text mining | PubMed |
| Identifying genes associated with Sorafenib resistance in hepatocellular carcinoma to develop risk model. | Discov Oncol | 2025 | 40835789 | PubTator, text mining | PubMed |
| Temporal Clonal Tracing Reveals Tumor-Intrinsic IFNγ-Dependencies Driving Niche Adaptation and Early Metastatic Colonization. | bioRxiv | 2025 | 40832237 | PubTator, text mining | PubMed |
| Multimodal profiling reveals tissue-directed signatures of human immune cells altered with age. | Nat Immunol | 2025 | 40804529 | PubTator, text mining | PubMed |
| Identification of novel molecular subtypes and construction of a prognostic signature via multi-omics analysis and machine learning in lung adenocarcinoma. | Front Oncol | 2025 | 40761262 | PubTator, text mining | PubMed |
| Multi-omics prediction of axillary treatment response and tumour microenvironment alterations in lymph node-positive luminal breast cancer. | Cell Death Dis | 2025 | 40759637 | PubTator, text mining | PubMed |
| Trained immunity in the lung. | Elife | 2025 | 40748050 | PubTator, text mining | PubMed |
| Heterogeneity of the liver cancer tumor microenvironment: mitochondrial metabolism and causal inference through Mendelian randomization. | Discov Oncol | 2025 | 40730701 | PubTator, text mining | PubMed |
| Tumor-associated macrophages: potential role in skeletal involvement in classic Hodgkin lymphoma. | J Pathol Clin Res | 2025 | 40704910 | PubTator, text mining | PubMed |
| IL7-IL7R Interaction Mediates Fibroblast-Driven Macrophage-to-Osteoclast Differentiation in Periodontitis. | J Inflamm Res | 2025 | 40386183 | PubTator, text mining | PubMed |
| Identification of novel potential biomarkers using bulk RNA and single cells to build a neural network model for diagnosis of liver cancer. | Discov Oncol | 2025 | 40353917 | PubTator, text mining | PubMed |
| Study of immunological and inflammatory gene response in Indian cohort of COVID- 19 patients by NanoString technology. | Immunol Res | 2025 | 40299133 | PubTator, text mining | PubMed |
| PTEN inhibits scavenger receptor-mediated phagocytosis of methicillin-resistant Staphylococcus aureus. | Immunohorizons | 2025 | 40288813 | PubTator, text mining | PubMed |
| Gene-by-environment interactions modulate the infant gut microbiota in asthma and atopy. | J Allergy Clin Immunol | 2025 | 40187613 | PubTator, text mining | PubMed |
| Class A Scavenger Receptor MARCO negatively regulates Ace expression and aldosterone production. | bioRxiv | 2025 | 40093086 | PubTator, text mining | PubMed |
| AXL promotes lymphangiogenesis by amplifying VEGF-C-mediated AKT pathway. | Cell Mol Life Sci | 2025 | 40011241 | PubTator, text mining | PubMed |
| SPP1hi macrophages, NKG7 T cells, CCL5hi fibroblasts, and IgM plasma cells are dominant features of necrobiosis. | JCI Insight | 2025 | 39989459 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8685/papers?page=4